SlideShare uma empresa Scribd logo
1 de 32
By- Prashant Tiwari
M.Pharma. (Pharmaceutics)
Columbia Institute of
Pharmacy, Raipur, C.G.
Introduction
 The Food and Drug Administration (FDA or USFDA)

is an agency of the United States Department of
Health and Human Services
 It is responsible for regulating and supervising the

safety of foods, dietary supplements, drugs, vaccines,
biological medical products, blood products, medical
devices, radiation-emitting devices, veterinary
products, and cosmetics
Cont….
 The FDA has its headquarters at White Oak, Maryland.

The agency also has 223 field offices and 13 laboratories
located throughout the 50 states, the United States Virgin
Islands and Puerto Rico.
 In 2008, the FDA started opening offices in foreign

countries, including China , India , Costa Rica , Chile ,
Belgium and the United Kingdom.
FDA-Organisations
 The Office of the Commissioner (OC)

 The Center for Drug Evaluation and Research (CDER)
 The Center for Biologics Evaluation and Research (CBER)
 The Center for Food Safety and Applied Nutrition (CFSAN)
 The Center for Devices and Radiological Health (CDRH)
 The Center for Veterinary Medicine (CVM)
 The National Center for Toxicological Research (NCTR)
 The Office of Regulatory Affairs (ORA)
FDA-Legal Authoritys
 1902 – Biologics Control Act
 1906 – Pure Food and Drug Act
 1938 – Federal Food, Drug, and Cosmetic Act
 1944 – Public Health Service Act
 1951 – Food, Drug, and Cosmetics Act Amendments
 1962 – Food, Drug, and Cosmetics Act Amendments
 1966 – Fair Packaging and Labeling Act
 1976 – Medical Device Regulation Act
 1987 – Prescription Drug Marketing Act
Cont…..
 1988 – Anti–drug Abuse Act
 1990 – Nutrition Labeling and Education Act
 1992 – Prescription Drug User Fee Act
 1994 – Dietary Supplement Health and Education Act
 1997 – Food and Drug Modernization Act

 2002 – Bioterrorism Act
 2002 – Medical Device User Fee and Modernization Act

(MDUFMA)
 2003 – Animal Drug User Fee Act
 2007 – Food and Drug Administration Amendments Act
of 2007
FDA- Mission
Maintaining of FDA
 The FDA consists of employees drawn from a wealth of

science

and

public

health

professions.

Biologists,

physicians, chemists, biomedical engineers, toxicologists,
pharmacologists, veterinarians, and specialists in the
public health education and communication.

 FDA employs approximately 11,516 people who work in

locations around the United States.
FDA regulate?
 Foods, except for most meat and poultry products, which are











regulated by the U.S. Department of Agriculture.
Food additives
Infant formulas ,Dietary supplements
Human drugs
Vaccines, blood products, and other biologics
Medical devices, from simple items like tongue depressors, to
complex technologies such as heart pacemakers.
Electronic products that give off radiation, such as microwave
ovens and X-ray equipment.
Cosmetics.
Feed, drugs, and devices used in pets, farm animals, and other
animals.
Tobacco products
FDA shares the responsibility for regulating these
products with other government agencies:
 Pesticides (FDA, the U.S. Department of Agriculture, and

the Environmental Protection Agency regulate these).
 Water (FDA regulates the labeling and safety of bottled

water, while the Environmental Protection Agency
develops national standards for drinking water from
municipal water supplies).
Job of the FDA
 The FDA is the U.S. Government agency that oversees

most foods and medical products.
 Its job is to make sure that: Food is safe, healthy, and

clean. Medicines and medical devices are reasonably safe
and effective. Cosmetic products are safe. Animal foods
and drugs are safe. Food and medical products have
proper labels.
Regulatory programs
 The programs for safety regulation vary widely by the

type of product, its potential risks, and the regulatory
powers granted to the agency.
 The FDA regulates most products with a set of published

standards enforced by a modest number of facility
inspections.
 Inspection observations are documented on Form 483 .
FDA Inspection
FDA inspects manufacturers or processors of FDA-regulated
products to verify that they comply with relevant regulations.
Inspection include:






vaccine and drug manufacturers
blood banks
food processing facilities dairy farms animal feed processors
Facilities that conduct studies in people (clinical trials).
Laboratories that conduct studies in animals or microorganisms
when these studies are used to apply for FDA approval of a
medical product.
 Foreign manufacturing and processing sites for FDA- regulated
products that are sold in the United States. Imported products at
the border.
Cont…..
FDA conducts several types of inspections to help
protect consumers from unsafe products
 Pre-approval inspection after a company submits
an application to FDA to market a new product.
 Routine inspection of a regulated facility
 For-cause inspection to investigate a specific
problem that has come to FDA ’ s attention.
FDA makes available to the public certain
frequently requested records of inspections in an
electronic reading room .
Cont…..
Review of FDA inspectional guides
 Investigations Operations Manual (IOM)
 Compliance Program Guidance Manuals
(CPGM)
 Compliance Policy Guides(CPG)
Inspection Technical Guides Review of firm’s
Establishment Inspection Report (EIR)
Responses to FDA Form 483 etc.
Planning of inspections
Forms Commonly Used During
FDA Inspections
 FDA Form 482: Notice of inspection.

 FDA Form 483: Inspectional

observations.
 FDA Form 484: Receipt for physical
evidence (e.g., samples) , but not for
documentary evidence (e.g., label, copy
of records…).
Recall?
 A recall is when a product is removed from the

market or a correction is made to the product
because it is either defective or potentially
harmful.
 Sometimes a company discovers a problem and
recalls a product on its own.
 Other times a company recalls a product after
FDA raises concerns
CFR Title 21
 C.F. R – Code of federal Regulaion is a codification of

general rules and regulations also known as administrative
law published in the federal register by the executive
department and agencies of federal government of united
states
 Title 21 of the CFR is reserved for rules of the Food and
Drug Administration.
 CFR 21 was received from the Government Printing
Office (GPO) and contains the most recently received
revision.
 Food and Drugs: Parts 1 to 1499 different types of parts
to food, drug , cosmetic and medical devices and etc
Cont…..
 21 CFR part 11- Electronic submission and Electronic










signature
21 CFR part 50- Protection of human subjects
21 CFR part 54- Financial Disclosure by Clinical
Investigators
21 CFR part 56- Institutional Review Board
21 CFR part 101-Food Labelling.
21 CFR part 104-Nutritional quality guidelines for foods
21 CFR part 106- Infant Formula Quality Control
Procedures
21 CFR part 110- Cgmp Practices in manufacturing
packing or holding human food.
Cont…..
 21 CFR part 210- Cgmp Practices in

manufacturing, packing or holding of
Drugs:General
 21 CFR part 211- Cgmp Practices for finished
pharmaceuticals
 21 CFR part 225- Cgmp Practices for medicated
feeds.
 21 CFR part 312- Investigational new drug
application
 21 CFR part 314- Application for FDA Approval
to Market a New Drug
 21 CFR part 600 to 680- For biological products
FDA Guidelines to conduct cGMP
in Pharma Indutry
21 CFR part 210- Cgmp Practices in

manufacturing, packing or holding of
Drugs:General
21 CFR part 211- Cgmp Practices for
finished pharmaceuticals
21 CFR 210
210.1- Status of Cgmp regulation.
210.2-Applicability of Cgmp

regulation.
210.3- Definitions.
21 CFR 211
Subpart A- General provision:
211.1-scope

Subpart B- Organisation and
Personnel:
211.22-Responsibility of quality control unit.
211.25-Personnel qualification.
211.28-Personnel responsibility.
211.34-Consultants
21 CFR 211
Subpart C- Building and facilities:
211.42-Design and construction features.
211.44-Lighting
211.46-Ventilation,air filtration,air heating and cooling
211.48-Plumbing
211.50-Sewage and refuse.
211.52- Washing and toilet facilites
211.56-Sanitization
211.58-Maintenance
21 CFR 211
Subpart D- Equipment:
211.63- Equip. design,size and location.
211.65- Equip. constrution
211.67- Equip. cleaning and maintenance
211.68- Automatic,machanical and electonic Equip.
211.72- Filters.
21 CFR 211
Subpart E- Control of components ,
drug product container and closures:
211.80- General requirement
211.82- Receipt & storage of untested components
211.84-Testing of approval or rejection of components
211.86-Use of approved components
211.87- Retesting of approved components
211.89- Rejected components
211.94- Drug product container and closures
21 CFR 211
Subpart F-Prodution and process controls:
211.100- Written procedure and deviation
211.101- Charge in of components
211.103- Calculation of yield
211.105- Equip. identification
211.110- Sampling and testing of in-process drug
product
211.111- Time limitation on prodution
211.113-Control on microbiological contamination
211.115- Reprocessing
21 CFR 211
Subpart G-Packing and labelling control
211.122- Material examination and usage criteria
211.125-Labelling issuance
211.130-Packing and labelling operation
211.132-Tamper evident packing requi.for OTC Drug
product
211.134-Drug product inspection.
211.137-Expiration dating
21 CFR 211
Subpart H-Holding &Distribution:
211.142- Ware house procedure
211.150- Distribution procedure

Subpart I- Laboratory control:
211.160- General requirement
211.165-Testing and release for distribution
211.166-Stability testing
211.167- Special testing requirement
211.170- Reserve samples
211.173- Laboratory animals
21 CFR 211
Subpart J-Record and reports:
211.180- General requirement
211.182- Equip. cleaning and use log
211.184- Component, drug product container &
labelling records
211.186- Master prodution and control records
211.188- Batch prodution and control records
211.192- Prodution record review
211.194- Laboratory records
211.196- Distribution records
211.198- Complaint files.
21 CFR 211
Subpart K- Returned and salvaged drug
product:
211.204- Returned drug product
211.208- Drug product salvaging.

----------------------------------------------------
THANK YOU

Mais conteúdo relacionado

Mais procurados

Common Technical Document
Common Technical DocumentCommon Technical Document
Common Technical DocumentDr Sukanta sen
 
Good laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticalsGood laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticalssrilakshmisadam
 
Regulatory requirements for drug approval
Regulatory requirements for drug approval Regulatory requirements for drug approval
Regulatory requirements for drug approval Namdeo Shinde
 
Common Technical Document (CTD)
Common Technical Document (CTD)Common Technical Document (CTD)
Common Technical Document (CTD)Swapnil Fernandes
 
New Drug Application(Nda) Vs Abbreviated New Drug Application (Anda)
New Drug Application(Nda) Vs Abbreviated New Drug Application (Anda)New Drug Application(Nda) Vs Abbreviated New Drug Application (Anda)
New Drug Application(Nda) Vs Abbreviated New Drug Application (Anda)Vamsikrishna Reddy
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsArpitha Aarushi
 
2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.Audumbar Mali
 
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesPharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesChintamBaladattaSai
 
central and state Regulatory bodies in India
central and state Regulatory bodies in Indiacentral and state Regulatory bodies in India
central and state Regulatory bodies in Indiasonaliph
 
Generic drugs product development
Generic drugs product developmentGeneric drugs product development
Generic drugs product developmentSachin G
 

Mais procurados (20)

Common Technical Document
Common Technical DocumentCommon Technical Document
Common Technical Document
 
ICH GUIDELINES
ICH GUIDELINESICH GUIDELINES
ICH GUIDELINES
 
Good laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticalsGood laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticals
 
Regulatory requirements for drug approval
Regulatory requirements for drug approval Regulatory requirements for drug approval
Regulatory requirements for drug approval
 
Common Technical Document (CTD)
Common Technical Document (CTD)Common Technical Document (CTD)
Common Technical Document (CTD)
 
ICH AND ICH GUIDELINES
ICH AND ICH GUIDELINESICH AND ICH GUIDELINES
ICH AND ICH GUIDELINES
 
New Drug Application(Nda) Vs Abbreviated New Drug Application (Anda)
New Drug Application(Nda) Vs Abbreviated New Drug Application (Anda)New Drug Application(Nda) Vs Abbreviated New Drug Application (Anda)
New Drug Application(Nda) Vs Abbreviated New Drug Application (Anda)
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of Biologics
 
Code of Federal Regulations
Code of Federal RegulationsCode of Federal Regulations
Code of Federal Regulations
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.
 
The introduction of an orange book
The introduction of an orange bookThe introduction of an orange book
The introduction of an orange book
 
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesPharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agencies
 
ICH guidelines (Q,S,E,M)
ICH guidelines (Q,S,E,M)ICH guidelines (Q,S,E,M)
ICH guidelines (Q,S,E,M)
 
ICH QSEM Guidelines
ICH QSEM GuidelinesICH QSEM Guidelines
ICH QSEM Guidelines
 
central and state Regulatory bodies in India
central and state Regulatory bodies in Indiacentral and state Regulatory bodies in India
central and state Regulatory bodies in India
 
Generic drugs product development
Generic drugs product developmentGeneric drugs product development
Generic drugs product development
 
Ich guidelines
Ich guidelinesIch guidelines
Ich guidelines
 
Regulatory Affairs Profession
Regulatory Affairs ProfessionRegulatory Affairs Profession
Regulatory Affairs Profession
 
Usfda
UsfdaUsfda
Usfda
 

Semelhante a USFDA GUIDLINES

Fda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science IndustryFda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science Industrydmanalan
 
US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.Venugopal N
 
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best PracticesAvoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best PracticesMaRS Discovery District
 
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...Jacobe2008
 
5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.Audumbar Mali
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalRajashri Survase Ojha
 
Working in a_regulated_environment_presentation_ngan-winward
Working in a_regulated_environment_presentation_ngan-winwardWorking in a_regulated_environment_presentation_ngan-winward
Working in a_regulated_environment_presentation_ngan-winwardbio-link
 
CODE OF FEDERAL REGULATION CFR.pptx
CODE OF FEDERAL REGULATION CFR.pptxCODE OF FEDERAL REGULATION CFR.pptx
CODE OF FEDERAL REGULATION CFR.pptxGaneshSureshKumbhar
 
FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...
FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...
FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...Path of the Blue Eye Project
 
GTPs vs. cGMPs
GTPs vs. cGMPsGTPs vs. cGMPs
GTPs vs. cGMPswrtolbert
 

Semelhante a USFDA GUIDLINES (20)

Fda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science IndustryFda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science Industry
 
USFDA Over View
USFDA  Over ViewUSFDA  Over View
USFDA Over View
 
Usfda swatee
Usfda swateeUsfda swatee
Usfda swatee
 
Usfda
Usfda Usfda
Usfda
 
Usfda sana 1
Usfda sana 1Usfda sana 1
Usfda sana 1
 
Industry and fda laision &
Industry and fda laision &Industry and fda laision &
Industry and fda laision &
 
US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.
 
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best PracticesAvoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
 
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
 
5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
 
What is FDA?
What is FDA?What is FDA?
What is FDA?
 
Usfda ppn
Usfda ppnUsfda ppn
Usfda ppn
 
QMS and GMP
QMS and GMPQMS and GMP
QMS and GMP
 
Working in a_regulated_environment_presentation_ngan-winward
Working in a_regulated_environment_presentation_ngan-winwardWorking in a_regulated_environment_presentation_ngan-winward
Working in a_regulated_environment_presentation_ngan-winward
 
CODE OF FEDERAL REGULATION CFR.pptx
CODE OF FEDERAL REGULATION CFR.pptxCODE OF FEDERAL REGULATION CFR.pptx
CODE OF FEDERAL REGULATION CFR.pptx
 
Roshan (1)
Roshan (1)Roshan (1)
Roshan (1)
 
FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...
FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...
FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...
 
GTPs vs. cGMPs
GTPs vs. cGMPsGTPs vs. cGMPs
GTPs vs. cGMPs
 
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)
 

Último

CHEST Proprioceptive neuromuscular facilitation.pptx
CHEST Proprioceptive neuromuscular facilitation.pptxCHEST Proprioceptive neuromuscular facilitation.pptx
CHEST Proprioceptive neuromuscular facilitation.pptxAneriPatwari
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...DhatriParmar
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQuiz Club NITW
 
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxBIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxSayali Powar
 
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxGrade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxkarenfajardo43
 
Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1GloryAnnCastre1
 
How to Manage Buy 3 Get 1 Free in Odoo 17
How to Manage Buy 3 Get 1 Free in Odoo 17How to Manage Buy 3 Get 1 Free in Odoo 17
How to Manage Buy 3 Get 1 Free in Odoo 17Celine George
 
MS4 level being good citizen -imperative- (1) (1).pdf
MS4 level   being good citizen -imperative- (1) (1).pdfMS4 level   being good citizen -imperative- (1) (1).pdf
MS4 level being good citizen -imperative- (1) (1).pdfMr Bounab Samir
 
4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptxmary850239
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseCeline George
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationdeepaannamalai16
 
4.9.24 School Desegregation in Boston.pptx
4.9.24 School Desegregation in Boston.pptx4.9.24 School Desegregation in Boston.pptx
4.9.24 School Desegregation in Boston.pptxmary850239
 
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...Nguyen Thanh Tu Collection
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfPatidar M
 
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...DhatriParmar
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptxDIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptxMichelleTuguinay1
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxlancelewisportillo
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvRicaMaeCastro1
 

Último (20)

CHEST Proprioceptive neuromuscular facilitation.pptx
CHEST Proprioceptive neuromuscular facilitation.pptxCHEST Proprioceptive neuromuscular facilitation.pptx
CHEST Proprioceptive neuromuscular facilitation.pptx
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
 
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxBIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
 
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxGrade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
 
Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1
 
How to Manage Buy 3 Get 1 Free in Odoo 17
How to Manage Buy 3 Get 1 Free in Odoo 17How to Manage Buy 3 Get 1 Free in Odoo 17
How to Manage Buy 3 Get 1 Free in Odoo 17
 
MS4 level being good citizen -imperative- (1) (1).pdf
MS4 level   being good citizen -imperative- (1) (1).pdfMS4 level   being good citizen -imperative- (1) (1).pdf
MS4 level being good citizen -imperative- (1) (1).pdf
 
4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 Database
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentation
 
Paradigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTAParadigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTA
 
4.9.24 School Desegregation in Boston.pptx
4.9.24 School Desegregation in Boston.pptx4.9.24 School Desegregation in Boston.pptx
4.9.24 School Desegregation in Boston.pptx
 
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdf
 
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptxDIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
 

USFDA GUIDLINES

  • 1. By- Prashant Tiwari M.Pharma. (Pharmaceutics) Columbia Institute of Pharmacy, Raipur, C.G.
  • 2. Introduction  The Food and Drug Administration (FDA or USFDA) is an agency of the United States Department of Health and Human Services  It is responsible for regulating and supervising the safety of foods, dietary supplements, drugs, vaccines, biological medical products, blood products, medical devices, radiation-emitting devices, veterinary products, and cosmetics
  • 3. Cont….  The FDA has its headquarters at White Oak, Maryland. The agency also has 223 field offices and 13 laboratories located throughout the 50 states, the United States Virgin Islands and Puerto Rico.  In 2008, the FDA started opening offices in foreign countries, including China , India , Costa Rica , Chile , Belgium and the United Kingdom.
  • 4. FDA-Organisations  The Office of the Commissioner (OC)  The Center for Drug Evaluation and Research (CDER)  The Center for Biologics Evaluation and Research (CBER)  The Center for Food Safety and Applied Nutrition (CFSAN)  The Center for Devices and Radiological Health (CDRH)  The Center for Veterinary Medicine (CVM)  The National Center for Toxicological Research (NCTR)  The Office of Regulatory Affairs (ORA)
  • 5. FDA-Legal Authoritys  1902 – Biologics Control Act  1906 – Pure Food and Drug Act  1938 – Federal Food, Drug, and Cosmetic Act  1944 – Public Health Service Act  1951 – Food, Drug, and Cosmetics Act Amendments  1962 – Food, Drug, and Cosmetics Act Amendments  1966 – Fair Packaging and Labeling Act  1976 – Medical Device Regulation Act  1987 – Prescription Drug Marketing Act
  • 6. Cont…..  1988 – Anti–drug Abuse Act  1990 – Nutrition Labeling and Education Act  1992 – Prescription Drug User Fee Act  1994 – Dietary Supplement Health and Education Act  1997 – Food and Drug Modernization Act  2002 – Bioterrorism Act  2002 – Medical Device User Fee and Modernization Act (MDUFMA)  2003 – Animal Drug User Fee Act  2007 – Food and Drug Administration Amendments Act of 2007
  • 8. Maintaining of FDA  The FDA consists of employees drawn from a wealth of science and public health professions. Biologists, physicians, chemists, biomedical engineers, toxicologists, pharmacologists, veterinarians, and specialists in the public health education and communication.  FDA employs approximately 11,516 people who work in locations around the United States.
  • 9. FDA regulate?  Foods, except for most meat and poultry products, which are          regulated by the U.S. Department of Agriculture. Food additives Infant formulas ,Dietary supplements Human drugs Vaccines, blood products, and other biologics Medical devices, from simple items like tongue depressors, to complex technologies such as heart pacemakers. Electronic products that give off radiation, such as microwave ovens and X-ray equipment. Cosmetics. Feed, drugs, and devices used in pets, farm animals, and other animals. Tobacco products
  • 10. FDA shares the responsibility for regulating these products with other government agencies:  Pesticides (FDA, the U.S. Department of Agriculture, and the Environmental Protection Agency regulate these).  Water (FDA regulates the labeling and safety of bottled water, while the Environmental Protection Agency develops national standards for drinking water from municipal water supplies).
  • 11. Job of the FDA  The FDA is the U.S. Government agency that oversees most foods and medical products.  Its job is to make sure that: Food is safe, healthy, and clean. Medicines and medical devices are reasonably safe and effective. Cosmetic products are safe. Animal foods and drugs are safe. Food and medical products have proper labels.
  • 12. Regulatory programs  The programs for safety regulation vary widely by the type of product, its potential risks, and the regulatory powers granted to the agency.  The FDA regulates most products with a set of published standards enforced by a modest number of facility inspections.  Inspection observations are documented on Form 483 .
  • 13. FDA Inspection FDA inspects manufacturers or processors of FDA-regulated products to verify that they comply with relevant regulations. Inspection include:      vaccine and drug manufacturers blood banks food processing facilities dairy farms animal feed processors Facilities that conduct studies in people (clinical trials). Laboratories that conduct studies in animals or microorganisms when these studies are used to apply for FDA approval of a medical product.  Foreign manufacturing and processing sites for FDA- regulated products that are sold in the United States. Imported products at the border.
  • 14. Cont….. FDA conducts several types of inspections to help protect consumers from unsafe products  Pre-approval inspection after a company submits an application to FDA to market a new product.  Routine inspection of a regulated facility  For-cause inspection to investigate a specific problem that has come to FDA ’ s attention. FDA makes available to the public certain frequently requested records of inspections in an electronic reading room .
  • 15. Cont….. Review of FDA inspectional guides  Investigations Operations Manual (IOM)  Compliance Program Guidance Manuals (CPGM)  Compliance Policy Guides(CPG) Inspection Technical Guides Review of firm’s Establishment Inspection Report (EIR) Responses to FDA Form 483 etc. Planning of inspections
  • 16. Forms Commonly Used During FDA Inspections  FDA Form 482: Notice of inspection.  FDA Form 483: Inspectional observations.  FDA Form 484: Receipt for physical evidence (e.g., samples) , but not for documentary evidence (e.g., label, copy of records…).
  • 17. Recall?  A recall is when a product is removed from the market or a correction is made to the product because it is either defective or potentially harmful.  Sometimes a company discovers a problem and recalls a product on its own.  Other times a company recalls a product after FDA raises concerns
  • 18. CFR Title 21  C.F. R – Code of federal Regulaion is a codification of general rules and regulations also known as administrative law published in the federal register by the executive department and agencies of federal government of united states  Title 21 of the CFR is reserved for rules of the Food and Drug Administration.  CFR 21 was received from the Government Printing Office (GPO) and contains the most recently received revision.  Food and Drugs: Parts 1 to 1499 different types of parts to food, drug , cosmetic and medical devices and etc
  • 19. Cont…..  21 CFR part 11- Electronic submission and Electronic        signature 21 CFR part 50- Protection of human subjects 21 CFR part 54- Financial Disclosure by Clinical Investigators 21 CFR part 56- Institutional Review Board 21 CFR part 101-Food Labelling. 21 CFR part 104-Nutritional quality guidelines for foods 21 CFR part 106- Infant Formula Quality Control Procedures 21 CFR part 110- Cgmp Practices in manufacturing packing or holding human food.
  • 20. Cont…..  21 CFR part 210- Cgmp Practices in manufacturing, packing or holding of Drugs:General  21 CFR part 211- Cgmp Practices for finished pharmaceuticals  21 CFR part 225- Cgmp Practices for medicated feeds.  21 CFR part 312- Investigational new drug application  21 CFR part 314- Application for FDA Approval to Market a New Drug  21 CFR part 600 to 680- For biological products
  • 21. FDA Guidelines to conduct cGMP in Pharma Indutry 21 CFR part 210- Cgmp Practices in manufacturing, packing or holding of Drugs:General 21 CFR part 211- Cgmp Practices for finished pharmaceuticals
  • 22. 21 CFR 210 210.1- Status of Cgmp regulation. 210.2-Applicability of Cgmp regulation. 210.3- Definitions.
  • 23. 21 CFR 211 Subpart A- General provision: 211.1-scope Subpart B- Organisation and Personnel: 211.22-Responsibility of quality control unit. 211.25-Personnel qualification. 211.28-Personnel responsibility. 211.34-Consultants
  • 24. 21 CFR 211 Subpart C- Building and facilities: 211.42-Design and construction features. 211.44-Lighting 211.46-Ventilation,air filtration,air heating and cooling 211.48-Plumbing 211.50-Sewage and refuse. 211.52- Washing and toilet facilites 211.56-Sanitization 211.58-Maintenance
  • 25. 21 CFR 211 Subpart D- Equipment: 211.63- Equip. design,size and location. 211.65- Equip. constrution 211.67- Equip. cleaning and maintenance 211.68- Automatic,machanical and electonic Equip. 211.72- Filters.
  • 26. 21 CFR 211 Subpart E- Control of components , drug product container and closures: 211.80- General requirement 211.82- Receipt & storage of untested components 211.84-Testing of approval or rejection of components 211.86-Use of approved components 211.87- Retesting of approved components 211.89- Rejected components 211.94- Drug product container and closures
  • 27. 21 CFR 211 Subpart F-Prodution and process controls: 211.100- Written procedure and deviation 211.101- Charge in of components 211.103- Calculation of yield 211.105- Equip. identification 211.110- Sampling and testing of in-process drug product 211.111- Time limitation on prodution 211.113-Control on microbiological contamination 211.115- Reprocessing
  • 28. 21 CFR 211 Subpart G-Packing and labelling control 211.122- Material examination and usage criteria 211.125-Labelling issuance 211.130-Packing and labelling operation 211.132-Tamper evident packing requi.for OTC Drug product 211.134-Drug product inspection. 211.137-Expiration dating
  • 29. 21 CFR 211 Subpart H-Holding &Distribution: 211.142- Ware house procedure 211.150- Distribution procedure Subpart I- Laboratory control: 211.160- General requirement 211.165-Testing and release for distribution 211.166-Stability testing 211.167- Special testing requirement 211.170- Reserve samples 211.173- Laboratory animals
  • 30. 21 CFR 211 Subpart J-Record and reports: 211.180- General requirement 211.182- Equip. cleaning and use log 211.184- Component, drug product container & labelling records 211.186- Master prodution and control records 211.188- Batch prodution and control records 211.192- Prodution record review 211.194- Laboratory records 211.196- Distribution records 211.198- Complaint files.
  • 31. 21 CFR 211 Subpart K- Returned and salvaged drug product: 211.204- Returned drug product 211.208- Drug product salvaging. ----------------------------------------------------